Published Sep 19, 2025 4 Min Read

Introduction

List of Sun Pharma Shares in India 2025

Sun Pharmaceutical Industries Ltd is one of India’s leading pharmaceutical companies, renowned for its specialty generic drugs and innovative healthcare solutions. This article explores the list of Sun Pharma shares, their history, key people driving the company, and answers common investor queries.

List of Muthoot Group Stocks

The Sun Pharma Group operates through several publicly traded entities. Here is a list of Sun Pharma shares along with their market capitalisations:

Company NameMarket Capitalisation (Approx.)
Sun Pharmaceutical Industries LtdRs. 2,30,000 crore
Sun Pharma Advanced Research Company LtdRs. 6,000 crore
Zenotech Laboratories LtdRs. 200 crore

Note: Market capitalisation figures are indicative and subject to change based on market conditions.

History of Sun Pharma

Established in 1983 by Dilip Shanghvi, Sun Pharmaceutical Industries Ltd began as a small company with a focus on psychiatry drugs. Over the years, it expanded its product portfolio to include cardiology, neurology, gastroenterology, and dermatology treatments. The company’s growth was further bolstered by strategic acquisitions, including Ranbaxy Laboratories in 2014, which made Sun Pharma the largest pharmaceutical company in India and one of the top global generic drug manufacturers. Today, it operates in over 100 countries, catering to diverse healthcare needs.

Key People in Sun Pharma

Sun Pharma’s success is attributed to its visionary leadership. Dilip Shanghvi, the founder and managing director, has been instrumental in shaping the company’s growth trajectory. Under his guidance, Sun Pharma has become a global leader in specialty generics. Other key figures include Sudhir Valia, a director with extensive financial expertise, and Abhay Gandhi, the CEO of Sun Pharma North America, who has played a pivotal role in expanding the company’s presence in international markets. Their collective expertise ensures Sun Pharma remains at the forefront of innovation and growth in the pharmaceutical industry.

Conclusion

Sun Pharma shares, along with its group companies, offers investors an insight into the world of pharmaceutical stocks. With a strong history, visionary leadership, and a robust product portfolio, Sun Pharma continues to be a trusted name in healthcare. However, investors should conduct thorough research and consult financial advisors before making investment decisions.

Disclaimer: Investments in securities markets are subject to market risks. Please read all scheme-related documents carefully before investing. Past performance is not indicative of future returns. Bajaj Broking does not provide investment advisory services.

Frequently Asked Questions

What is the stock symbol of Sun Pharma?

The stock symbol of Sun Pharmaceutical Industries Ltd is SUNPHARMA on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).

Is Sun Pharma a good company to invest in?

Sun Pharma is a leading pharmaceutical company with a strong track record of innovation and growth. However, whether it is a good investment depends on individual financial goals, market conditions, and risk appetite. Investors should perform due diligence or consult financial advisors before investing.

What does Sun Pharma specialize in?

Sun Pharma specializes in specialty generics, over-the-counter (OTC) products, and active pharmaceutical ingredients (APIs). Its product portfolio spans treatments for cardiology, neurology, oncology, dermatology, and more.

Does Sun Pharma pay dividends?

Yes, Sun Pharma has a history of paying dividends to its shareholders. The dividend amount and frequency depend on the company’s financial performance and board decisions.

Show More Show Less

Bajaj Finserv App for all your financial needs and goals

Trusted by 50 million+ customers in India, Bajaj Finserv App is a one-stop solution for all your financial needs and goals.

You can use the Bajaj Finserv App to:

Apply for loans online, such as Instant Personal Loan, Home Loan, Business Loan, Gold Loan, and more.

  • Explore and apply for co-branded credit cards online.
  • Invest in fixed deposits and mutual funds on the app.
  • Choose from multiple insurance for your health, motor and even pocket insurance, from various insurance providers.
  • Pay and manage your bills and recharges using the BBPS platform. Use Bajaj Pay and Bajaj Wallet for quick and simple money transfers and transactions.
  • Apply for Insta EMI Card and get a pre-approved limit on the app. Explore over 1 million products on the app that can be purchased from a partner store on Easy EMIs.
  • Shop from over 100+ brand partners that offer a diverse range of products and services.
  • Use specialised tools like EMI calculators, SIP Calculators
  • Check your credit score, download loan statements, and even get quick customer support—all on the app.

Download the Bajaj Finserv App today and experience the convenience of managing your finances on one app.

Standard Disclaimer

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Research Disclaimer

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking) | REG OFFICE: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corp. Office: Bajaj Broking., 1st Floor, Mantri IT Park, Tower B, Unit No 9 &10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Website: https://www.bajajbroking.in/

Research Services are offered by Bajaj Financial Securities Limited as Research Analyst under SEBI Registration No.: INH000010043.

Details of Compliance Officer: Mr. Harinatha Reddy Muthumula (For Broking/DP/Research) | Email: compliance_sec@bajajfinserv.in/Compliance_dp@bajajfinserv.in | Contact No.: 020-4857 4486 | This content is for educational purpose only.

Investment in the securities involves risks, investor should consult his own advisors/consultant to determine the merits and risks of investment.

Disclaimer

1. Bajaj Finance Limited (“BFL”) is a Non-Banking Finance Company (NBFC) and Prepaid Payment Instrument Issuer offering financial services viz., loans, deposits, Bajaj Pay Wallet, Bajaj Pay UPI, bill payments and third-party wealth management products. The details mentioned in the respective product/ service document shall prevail in case of any inconsistency with respect to the information referring to BFL products and services on this page.

2. All other information, such as, the images, facts, statistics etc. (“information”) that are in addition to the details mentioned in the BFL’s product/ service document and which are being displayed on this page only depicts the summary of the information sourced from the public domain. The said information is neither owned by BFL nor it is to the exclusive knowledge of BFL. There may be inadvertent inaccuracies or typographical errors or delays in updating the said information. Hence, users are advised to independently exercise diligence by verifying complete information, including by consulting experts, if any. Users shall be the sole owner of the decision taken, if any, about suitability of the same.